K Charles Janac Sells 17,856 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 17,856 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $10.12, for a total transaction of $180,702.72. Following the sale, the chief executive officer now directly owns 10,287,435 shares of the company’s stock, valued at $104,108,842.20. The trade was a 0.17 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

K Charles Janac also recently made the following trade(s):

• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The stock was sold at an average price of $8.58, for a total value of $10,656.36.
• On Wednesday, October 2nd, K Charles Janac sold 5,520 shares of Arteris stock. The stock was sold at an average price of $7.18, for a total value of $39,633.60.

Arteris Trading Up 1.5 %

NASDAQ:AIP opened at $10.29 on Friday. The company has a market capitalization of $413.42 million, a P/E ratio of -10.72 and a beta of 1.25. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. Arteris, Inc. has a 12 month low of $4.83 and a 12 month high of $10.60. The firm has a fifty day simple moving average of $8.00 and a 200-day simple moving average of $7.83.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.

Hedge Funds Weigh In On Arteris

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. US Bancorp DE purchased a new stake in Arteris during the 3rd quarter valued at about $34,000. The Manufacturers Life Insurance Company purchased a new stake in Arteris in the second quarter valued at approximately $86,000. Algert Global LLC acquired a new position in Arteris in the 2nd quarter worth approximately $115,000. MetLife Investment Management LLC raised its position in Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Arteris during the 3rd quarter valued at approximately $226,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.